Sorrel Wolowacz - Concepedia

Author

Sorrel Wolowacz

Also Known As

Msc Sorrel Wolowacz, S Wolowacz, S. E. Wolowacz, S. Wolowacz, S.E. Wolowacz, Sorrel E Wolowacz, Sorrel E. Wolowacz, Sorrel Wolowacz

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (France)RTI Health Solutions GlaxoSmithKline (Germany)Middlesex University University of Manchester

About

Sorrel Wolowacz is an author at GlaxoSmithKline (France) specializing in medicine, economic evaluation, and outcomes research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	820
2	Public Health	3	3	436
3	Health Policy	3	3	436
4	Family Medicine	1	1	54
5	Immunology	1	1	16

Sorrel Wolowacz

Publications

994

Citations

H-Index

Page 1

	Year	Citations
Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision A. R. McLellan, Sorrel Wolowacz, Evelina A. Zimovetz, Osteoporosis International Skeletal TraumaHealth EconomicsHealth PolicyService ProvisionOutcomes Research	2011	251
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty Neil Roskell, Jonathan Plumb, Joseph A. Caprini, Thrombosis and Haemostasis ThrombosisVenous ThrombosisDabigatran EtexilateOsteoarthritisOrthopaedics	2008	181
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report Sorrel Wolowacz, Andrew Briggs, Vasily Belozeroff, Value in Health Healthcare ValueHealth EconomicsHealth PolicyEconomic ModelsMedicine	2016	158
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Sorrel Wolowacz, Neil S. Roskell, Fiona Maciver, Clinical Therapeutics ThrombosisVenous ThrombosisDabigatran EtexilateTotal KneeOrthopaedics	2009	79
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS) Stefan Andreas, C. Chouaïd, Sarah Danson, Lung Cancer	2018	67
Predictors of health-related quality of life in sufferers with restless legs syndrome: A multi-national study Louise McCrink, Richard P. Allen, Sorrel Wolowacz, Sleep Medicine Quality Of LifeSleepFamily MedicineMulti-national StudyLife Assessment	2006	54
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study C. Chouaïd, Sarah Danson, Stefan Andreas, Lung Cancer	2018	41
Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis Sorrel Wolowacz, David Cameron, Helen Tate, Journal of Clinical Oncology	2008	40
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement Neil Roskell, Jonathan Plumb, Andreas Clemens, Thrombosis and Haemostasis ThrombosisPulmonary EmbolismVenous ThrombosisOral Dabigatran EtexilateDabigatran Etexilate	2009	33
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study) Florent Grange, Peter Mohr, Mark Harries, Melanoma Research Surgical OncologyHealth OutcomeCancer ManagementPathologyCancer Registration	2017	27

Page 1